HERON THERAPEUTICS, INC. short interest in 2024
In 2024, HERON THERAPEUTICS, INC.'s disclosed short interest ran from 14.34% of shares outstanding on 12 Jan 2024 to 20.19% on 31 Dec 2024, a change of +5.85 percentage points. The year's high was 23.71% on 15 Aug 2024 and its low 14.34% on 12 Jan 2024, averaging 19.54% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.88 days on 30 Aug 2024. Full history: HERON THERAPEUTICS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 14.34% (12 Jan 2024)
- End of year
- 20.19% (31 Dec 2024)
- Change
- +5.85 pp
- High
- 23.71% (15 Aug 2024)
- Low
- 14.34% (12 Jan 2024)
- Average
- 19.54%
- Highest days to cover
- 25.88 (30 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 14.34% | 5.37 | |
| 31 Jan 2024 | 16.21% | 5.49 | |
| 15 Feb 2024 | 16.40% | 11.36 | |
| 29 Feb 2024 | 16.35% | 14.80 | |
| 15 Mar 2024 | 16.94% | 6.58 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 17.03% | 15.50 | |
| 15 Apr 2024 | 16.95% | 18.57 | |
| 30 Apr 2024 | 18.19% | 11.37 | |
| 15 May 2024 | 20.09% | 12.51 | 10-Q filed, results (8-K) |
| 31 May 2024 | 19.94% | 11.11 | |
| 14 Jun 2024 | 20.22% | 20.38 | |
| 28 Jun 2024 | 21.79% | 11.72 | |
| 15 Jul 2024 | 23.67% | 14.63 | |
| 31 Jul 2024 | 23.65% | 16.82 | |
| 15 Aug 2024 | 23.71% | 10.07 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 23.68% | 25.88 | |
| 13 Sep 2024 | 23.37% | 21.32 | |
| 30 Sep 2024 | 20.90% | 13.00 | |
| 15 Oct 2024 | 20.20% | 22.12 | |
| 31 Oct 2024 | 19.00% | 20.25 | |
| 15 Nov 2024 | 18.35% | 11.70 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 18.11% | 18.87 | |
| 13 Dec 2024 | 19.71% | 2.87 | |
| 31 Dec 2024 | 20.19% | 16.21 |
See also: HERON THERAPEUTICS, INC.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.